Abstract
Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Dendritic Cell Vaccine and Cancer Treatment: New Patents
Volume: 8 Issue: 1
Author(s): Andre A.R. Aleixo, Marcia A. Michelin and Eddie F.C. Murta
Affiliation:
Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.
Abstract: Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
Export Options
About this article
Cite this article as:
Aleixo A.R. Andre, Michelin A. Marcia and Murta F.C. Eddie, Dendritic Cell Vaccine and Cancer Treatment: New Patents, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2014; 8 (1) . https://dx.doi.org/10.2174/1872214807666140107152008
DOI https://dx.doi.org/10.2174/1872214807666140107152008 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Applicability and Approaches of (Meth) Acrylate Copolymers (Eudragits) in Novel Drug Delivery Systems
Current Drug Therapy Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Current Cancer Drug Targets Binding of Tris to Bacillus licheniformis α-Amylase Can Affect Its Starch Hydrolysis Activity
Protein & Peptide Letters The CLCA Gene Family A Novel Family of Putative Chloride Channels
Current Genomics The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Mechanisms of Viral Hepatitis Induced Liver Injury
Current Molecular Medicine The Role of Biomarker Genes in the Diagnosis and Treatment of Nonsmall Cell Lung Cancer
Current Respiratory Medicine Reviews γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Nanotechnological Strategies for the Treatment of Neglected Diseases
Current Pharmaceutical Design Enjoy the Silence: The Story of let-7 MicroRNA and Cancer
Current Genomics Applications of Computed Tomography, Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy for Planning External Beam Radiotherapy
Current Medical Imaging Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design Plasminogen Activator Inhibitor with Very Long Half-life (VLHL PAI-1) can Reduce Bleeding in PAI-1-deficient Patients
Cardiovascular & Hematological Disorders-Drug Targets Formulation, Characterization and In vitro Cytotoxicity of 5-Fluorouracil Loaded Polymeric Electrospun Nanofibers for the Treatment of Skin Cancer
Recent Patents on Nanotechnology Multi-Target Profile of Oleocanthal, An Extra-Virgin Olive Oil Component
Current Bioactive Compounds The Pim Kinases: New Targets for Drug Development
Current Drug Targets The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
Reviews on Recent Clinical Trials